Intermediate HER2 expression is associated with poor prognosis in estrogen receptor-positive breast cancer patients aged 55 years and older

被引：0
作者：
Min Hwan Kim
Gun Min Kim
Jee Hung Kim
Jee Ye Kim
Hyung Seok Park
Seho Park
Young Up Cho
Byeong Woo Park
Seung Il Kim
Joohyuk Sohn
机构：
[1] Yonsei University College of Medicine,Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center
[2] Gangnam Severance Hospital,Division of Medical Oncology, Department of Internal Medicine
[3] Yonsei University College of Medicine,Division of Breast Surgery, Department of Surgery, Yonsei Cancer Center
[4] Yonsei University College of Medicine,undefined
来源：
Breast Cancer Research and Treatment | 2020年 / 179卷
关键词：
Intermediate HER2; Age; Prognosis; Metastatic breast cancer; Early breast cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：687 / 697
页数：10
相关论文
共 50 条
  • [1] Intermediate HER2 expression is associated with poor prognosis in estrogen receptor-positive breast cancer patients aged 55 years and older
    Kim, Min Hwan
    Kim, Gun Min
    Kim, Jee Hung
    Kim, Jee Ye
    Park, Hyung Seok
    Park, Seho
    Cho, Young Up
    Park, Byeong Woo
    Kim, Seung Il
    Sohn, Joohyuk
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 179 (03) : 687 - 697
  • [2] Should we target "intermediate expression" of HER2 in older estrogen receptor positive patients?
    Tokumaru, Yoshihisa
    Le, Lan
    Asaoka, Mariko
    Futamura, Manabu
    Ishikawa, Takashi
    Yoshida, Kazuhiro
    Takabe, Kazuaki
    TRANSLATIONAL CANCER RESEARCH, 2020, 9 (07) : 4056 - 4059
  • [3] Expression of c-MET in Estrogen Receptor Positive and HER2 Negative Resected Breast Cancer Correlated with a Poor Prognosis
    Iovino, Francesco
    Diana, Anna
    Carlino, Francesca
    Ferraraccio, Franca
    Antoniol, Giuliano
    Fisone, Francesca
    Perrone, Alessandra
    Zito Marino, Federica
    Panarese, Iacopo
    Tathode, Madhura S.
    Caraglia, Michele
    Gatta, Gianluca
    Ruggiero, Roberto
    Parisi, Simona
    De Vita, Ferdinando
    Ciardiello, Fortunato
    Docimo, Ludovico
    Orditura, Michele
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (23)
  • [4] HER2 positivity is not associated with adverse prognosis in high-risk estrogen receptor-positive early breast cancer patients treated with chemotherapy and trastuzumab
    Li, Shuai
    Wu, Jiayi
    Huang, Ou
    He, Jianrong
    Zhu, Li
    Chen, Weiguo
    Li, Yafen
    Chen, Xiaosong
    Shen, Kunwei
    BREAST, 2020, 54 : 235 - 241
  • [5] The Prognosis of Single Hormone Receptor-Positive Breast Cancer Stratified by HER2 Status
    Zhao, Hengqiang
    Gong, Yiping
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [6] Progesterone receptor status in determining the prognosis of estrogen receptor positive/HER2 negative breast carcinoma patients
    Bal, Oznur
    Arslan, Ulku Yalcintas
    Durnali, Ayse
    Uyetrk, Ummugul
    Demirci, Ayse
    Tastekin, Didem
    Ekinci, Ahmet
    Esbah, Onur
    Turker, Ibrahim
    Sonmez, Ozlem Uysal
    Oksuzoglu, Berna
    JOURNAL OF BUON, 2015, 20 (01): : 28 - 34
  • [7] Increased Expression of Forkhead Box M1 Is Associated with Aggressive Phenotype and Poor Prognosis in Estrogen Receptor-Positive Breast Cancer
    Ahn, Hyein
    Sim, Jongmin
    Abdul, Rehman
    Chung, Min Sung
    Paik, Seung Sam
    Oh, Young-Ha
    Park, Chan Kum
    Jang, Kiseok
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2015, 30 (04) : 390 - 397
  • [8] HER2 positivity in patients with estrogen receptor (ER) positive breast cancer: Is it really prognostic?
    Batra, Atul
    Kumar, Akash
    BREAST, 2021, 55 : 136 - 136
  • [9] Co-expression of SNAIL and TWIST determines prognosis in estrogen receptor-positive early breast cancer patients
    van Nes, Johanna G. H.
    de Kruijf, Esther M.
    Putter, Hein
    Faratian, Dana
    Munro, Alison
    Campbell, Fiona
    Smit, Vincent T. H. B. M.
    Liefers, Gerrit-Jan
    Kuppen, Peter J. K.
    van de Velde, Cornelis J. H.
    Bartlett, John M. S.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 133 (01) : 49 - 59
  • [10] Clinical Implication of HER2 Status in Hormone Receptor-Positive Mucinous Breast Cancer
    Gwark, Sung-chan
    Lee, Han Shin
    Lee, Youngjoo
    Lee, Sae Byul
    Sohn, Guiyun
    Kim, Jisun
    Chung, Il Yong
    Ko, Beom Seok
    Kim, Hee Jeong
    Son, Byung Ho
    Ahn, Jin-Hee
    Jung, Kyung Hae
    Kim, Sung-Bae
    Lee, Hee Jin
    Gong, Gyung-Yub
    Ahn, Sei Hyun
    Lee, Jong Won
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (07) : 2166 - 2174
12345